Co-Diagnostics, Inc. Common Stock Cash Flow Reinvestment Rate
Co-Diagnostics, Inc. Common Stock cash flow reinvestment rate. Co-Diagnostics, Inc. Common Stock (CODX) has a Cash Flow Reinvestment Rate of 4.65x as of September 2022, reinvesting $5.20 Million (capex $230.05K plus investments $4.97 Million) from operating cash flow of $1.12 Million. Explore Co-Diagnostics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Co-Diagnostics, Inc. Common Stock (2020–2022)
Cash flow reinvestment rate of Co-Diagnostics, Inc. Common Stock from 2020 to 2022. Historical reinvestment intensity for Co-Diagnostics, Inc. Common Stock across 3 annual periods. Explore Co-Diagnostics, Inc. Common Stock (CODX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Co-Diagnostics, Inc. Common Stock Cash Flow Reinvestment Rate by Year (2020–2022)
Co-Diagnostics, Inc. Common Stock cash flow reinvestment rate by year from 2020 to 2022. Year-by-year capital reinvestment analysis for Co-Diagnostics, Inc. Common Stock. For the full cash flow conversion analysis, see Co-Diagnostics, Inc. Common Stock operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 8.86x | $58.17 Million | $6.57 Million | $1.43 Million | ▲ +8477.1% |
| 2021 | 0.10x | $4.24 Million | $41.08 Million | $669.46K | ▼ -55.9% |
| 2020 | 0.23x | $6.60 Million | $28.17 Million | $774.40K | — |